The oncology acute toxicity unit (OATU): An outpatient facility for improving the management of chemotherapy toxicity

Clinical and Translational Oncology

Volumn 9, Issue 12, 2007, Pages 784-788

  Majem, M ^a   Galan M ^a   Perez F J ^a   Munoz M ^a   Chicote, S ^a   Soler, G ^a   Navarro, M ^a   Martinez Villacampa M ^a   Garcia del Muro X ^a   Dotor, E ^a   Laquente, B ^a   Germa J R ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Acute toxicity; Chemotherapy; Outpatient; Telephone helpline

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; METHOTREXATE; NAVELBINE; OXALIPLATIN;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLADDER CANCER; BLEEDING; BREAST CANCER; CHEMOTHERAPY INDUCED EMESIS; COLORECTAL CANCER; DIARRHEA; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INFORMATION; ESOPHAGUS CANCER; FEBRILE NEUTROPENIA; FEMALE; GERM CELL TUMOR; HEAD AND NECK CANCER; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; ONCOLOGY ACUTE TOXICITY UNIT; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; OVARY CANCER; PATIENT INFORMATION; SARCOMA; STOMACH CANCER; TELECONSULTATION; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; ADOLESCENT; CANCER CENTER; CHEMICALLY INDUCED DISORDER; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; MIDDLE AGED; NEOPLASM; ORGANIZATION AND MANAGEMENT; TELEPHONE; TOXICOLOGY; UTILIZATION REVIEW; VOMITING;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTINEOPLASTIC AGENTS; DRUG TOXICITY; FEMALE; HOTLINES; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; ONCOLOGY SERVICE, HOSPITAL; OUTPATIENT CLINICS, HOSPITAL; TELEPHONE; TOXICOLOGY; VOMITING;

EID: 39149118056     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0140-2     Document Type: Article

References (6)

1. Hoagland HC, Gastineau DA (1996) Hematologic complications of cancer chemotherapy. In: Perri MC (ed.) The chemotherapy source book, 2nd Edn. Williams and Wilkins, Baltimore, MD, pp 433-447
2. Johnston EM, Crawford J (1998) Hematopoietic growth factors in the reduction of chemotherapeutic toxicity. Semin Oncol 25:552-561
3. Mitchel EP, Schein PS (1982) Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 9:52-64
4. Peterson D (1984) Toxicity of chemotherapy: Oral lesions. In: Perry MC, Yarbro KW (eds) Toxicity of chemotherapy. Grune and Straton Inc, Orlando, pp 155-180
5. Mitchell EP, Glicksman AS, Schein PS (1993) Acute and late effects of cancer therapy and their management. In: Calabresi P, Schein PS (eds) Medical oncology, 2nd Edn. McGraw-Hill, pp 345-364
6. Cheng JD, Adams GP, Robinson MK, Weiner LM (2005) Pharmacology of cancer biotherapeutics: Monoclonal antibodies. In: DeVita VT Jr, Hellman S, Rosemberg SA (eds) Cancer. Principles and practice of oncology. Lippincott Williams and Wilkins, Philadelphia, USA